The administration of probiotics and synbiotics in immune compromised adults: is it safe?
In: Beneficial MicrobesSearch for other papers by M. Van den Nieuwboer in
Current site
Google Scholar
Search for other papers by R.J. Brummer in
Current site
Google Scholar
Search for other papers by F. Guarner in
Current site
Google Scholar
Search for other papers by L. Morelli in
Current site
Google Scholar
Search for other papers by M. Cabana in
Current site
Google Scholar
Search for other papers by E. Claassen in
Current site
Google Scholar
This study aimed to systematically evaluate safety of probiotics and synbiotics in immune compromised adults (≥18 years). Safety was analysed using the Common Terminology Clinical Adverse Events (CTCAE version 4.0) classification, thereby providing an update on previous reports using the most recent available clinical data (2008-2013). Safety aspects are represented and related to number of participants per probiotic strain/culture, study duration, dosage, clinical condition and selected afflictions. Analysis of 57 clinical studies indicates that probiotic and/or synbiotic administration in immune compromised adults is safe with regard to the current evaluated probiotic strains, dosages and duration. Individuals were considered immune compromised if HIV-infected, critically ill, underwent surgery or had an organ- or an autoimmune disease. There were no major safety concerns in the study, as none of the serious adverse events (AE)s were related, or suspected to be related, to the probiotic or synbiotic product and the study products were well tolerated. Overall, AEs occurred less frequent in immune compromised subjects receiving probiotics and/or synbiotics compared to the control group. In addition, the results demonstrated a flaw in precise reporting and classification of AE in most studies. Furthermore, generalisability of conclusions are greatly limited by the inconsistent, imprecise and potentially incomplete reporting as well as the variation in probiotic strains, dosages, administration regimes, study populations and reported outcomes. We argue that standardised reporting on adverse events (CTCAE) in ‘food’ studies should be obligatory, thereby improving reliability of data and re-enforcing the safety profile of probiotics.
-
Agrawal, A., Sharma, B.C., Sharma, P. and Sarin, S.K., 2012. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. American Journal of Gastroenterology 107: 1043-1050.
'Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy ' () 107 American Journal of Gastroenterology : 1043 -1050.
-
Alfaleh, K. and Bassler, D., 2008. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Systemic Review CD005496.
'Probiotics for prevention of necrotizing enterocolitis in preterm infants ' () Cochrane Database Systemic Review CD005496 .
-
Alonso, V.R. and Guarner, F., 2013. Linking the gut microbiota to human health. British Journal of Nutrition 109: S21-S26.
'Linking the gut microbiota to human health ' () 109 British Journal of Nutrition : S21 -S26.
-
Alverdy, J.C., Laughlin, R.S. and Wu, L., 2003. Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Critical Care Medicine 31: 598-607.
'Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined ' () 31 Critical Care Medicine : 598 -607.
-
Antoni, L., Nuding, S., Wehkamp, J. and Stange, E.F., 2014. Intestinal barrier in inflammatory bowel disease. World Journal of Gastroenteroly 20: 1165-1179.
'Intestinal barrier in inflammatory bowel disease ' () 20 World Journal of Gastroenteroly : 1165 -1179.
-
Anukam, K.C., Osazuwa, E.O., Osadolor, H.B., Bruce, A.W. and Reid, G., 2008. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. Journal Of Clinical Gastroenterology 42: 239-243.
'Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients ' () 42 Journal Of Clinical Gastroenterology : 239 -243.
-
Baigrie, R.J., Lamont, P.M., Kwiatkowski, D., Dallman, M.J. and Morris, P.J., 1992. Systemic cytokine response after major surgery. British Journal of Surgery 79: 757-760.
'Systemic cytokine response after major surgery ' () 79 British Journal of Surgery : 757 -760.
-
Barraud, D., Blard, C., Hein, F., Marçon, O., Cravoisy, A., Nace, L., Alla, F., Bollaert, P.E. and Gibot, S., 2010. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Medicine 36: 1540-1547.
'Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial ' () 36 Intensive Care Medicine : 1540 -1547.
-
Barraud, D., Bollaert, P.E. and Gibot, S., 2013. Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials. Chest 143: 646-655.
'Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials ' () 143 Chest : 646 -655.
-
Besselink, M.G.H., Timmerman, H.M., Van Minnen, L.P., Akkermans, L.M.A. and Gooszen, H.G., 2005. Prevention of infectious complications in surgical patients: potential role of probiotics. Digestive Surgery 22: 234-244.
'Prevention of infectious complications in surgical patients: potential role of probiotics ' () 22 Digestive Surgery : 234 -244.
-
Besselink, M.G., Van Santvoort, H.C., Buskens, E., Boermeester, M.A., Van Goor, H., Timmerman, H.M., Nieuwenhuijs, V.B., Bollen, T.L., Van Ramshorst, B., Witteman, B.J.M., Rosman, C., Ploeg, R.J., Brink, M.A., Schaapherder, A.F.M., Dejong, C.H.C., Wahab, P.J., Van Laarhoven, C.J.H.M., Van der Harst, E., Van Eijck, C.H.J., Cuesta, M.A., Akkermans, L.M.A. and Gooszen, H.G., 2008. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. The Lancet 371: 651-659.
'Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial ' () 371 The Lancet : 651 -659.
-
Bouilly-Gauthier, D., Jeannes, C., Maubert, Y., Duteil, L., Queille-Roussel, C., Piccardi, N., Montastier, C., Manissier, P., Piérard, G. and Ortonne, J.P., 2010. Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage. British Journal of Dermatology 163: 536-543.
'Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage ' () 163 British Journal of Dermatology : 536 -543.
-
Brenchley, J.M., Price, D.A., Schacker, T.W., Asher, T.E., Silvestri, G., Rao, S., Kazzaz, Z., Borstein, E., Lambotte, O., Altmann, D., Blazar, B.R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J.N., Hecht, F.M., Picker, L.J., Lederman, M.M., Deeks, S.G. and Douek, D.C., 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 12: 1365-1371.
'Microbial translocation is a cause of systemic immune activation in chronic HIV infection ' () 12 Nature Medicine : 1365 -1371.
-
Chitapanarux, I., Chitapanarux, T., Traisathit, P., Kudumpee, S., Tharavichitkul, E. and Lorvidhaya, V., 2010. Research randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiation Oncology 5: 31.
'Research randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients ' () 5 Radiation Oncology : 31.
-
Cimperman, L., Bayless, G., Best, K., Diligente, A., Mordarski, B., Oster, M., Smith, M., Vatakis, F., Wiese, D., Steiber, W. and Katz, J., 2011. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. Journal of Clinical Gastroenterology 45: 785-789.
'A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults ' () 45 Journal of Clinical Gastroenterology : 785 -789.
-
Claassen, E., Essbai, J., Rutgers, T. and Van Deventer, S., 2010. How safe are probiotics? Part 2: literature. Available at: http://www.infectieziektenplatform.nl/specialisme/hepatitis/33111
-
Clayburgh, D.R., Shen, L. and Turner, J.R., 2004. A porous defense: the leaky epithelial barrier in intestinal disease. Laboratory Investigation 84: 282-291.
'A porous defense: the leaky epithelial barrier in intestinal disease ' () 84 Laboratory Investigation : 282 -291.
-
Dandekar, S., 2007. Pathogenesis of HIV in the gastrointestinal tract. Current HIV/AIDS Reports 4: 10-15.
'Pathogenesis of HIV in the gastrointestinal tract ' () 4 Current HIV/AIDS Reports : 10 -15.
-
De los Angeles Pineda, M., Thompson, S.F., Summers, K., De Leon, F., Pope, J. and Reid, G., 2011. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Medical Science Monitor 17: CR347.
'A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis ' () 17 Medical Science Monitor : CR347.
-
Diepenhorst, G.M., Van Ruler, O., Besselink, M G., Van Santvoort, H.C., Wijnandts, P.R., Renooij, W., Gouma, D.J., Gooszen, H.G. and Boermeester, M.A., 2011. Influence of prophylactic probiotics and selective decontamination on bacterial translocation in patients undergoing pancreatic surgery: a randomized controlled trial. Shock 35: 9-16.
'Influence of prophylactic probiotics and selective decontamination on bacterial translocation in patients undergoing pancreatic surgery: a randomized controlled trial ' () 35 Shock : 9 -16.
-
Ebert, E.C. and Hagspiel, K.D., 2011. Gastrointestinal and hepatic manifestations of rheumatoid arthritis. Digestive Diseases and Sciences 56: 295-302.
'Gastrointestinal and hepatic manifestations of rheumatoid arthritis ' () 56 Digestive Diseases and Sciences : 295 -302.
-
Eguchi, S., Takatsuki, M., Hidaka, M., Soyama, A., Ichikawa, T. and Kanematsu, T., 2011. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. American Journal of Surgery 201: 498-502.
'Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study ' () 201 American Journal of Surgery : 498 -502.
-
Fernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V. and Rodés, J., 2002. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35: 140-148.
'Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis ' () 35 Hepatology : 140 -148.
-
Ferrie, S. and Daley, M., 2011. Lactobacillus GG as treatment for diarrhea during enteral feeding in critical illness randomized controlled trial. Journal of Parenteral and Enteral Nutrition 35: 43-49.
'Lactobacillus GG as treatment for diarrhea during enteral feeding in critical illness randomized controlled trial ' () 35 Journal of Parenteral and Enteral Nutrition : 43 -49.
-
Fiuza, C., Salcedo, M., Clemente, G., and Tellado, J. M., 2000. in vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. Journal of Infectious Diseases, 182(2), 526-533.
'in vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease ' () 182 Journal of Infectious Diseases : 526 -533.
-
Fleming, J.O., Isaak, A., Lee, J.E., Luzzio, C.C., Carrithers, M.D., Cook, T.D., Field, A.S., Boland, J. and Fabry, Z., 2011. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Multiple Sclerosis Journal 17: 743-754.
'Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study ' () 17 Multiple Sclerosis Journal : 743 -754.
-
Food and Agriculture Organization of the United Nations (FAO), 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available at: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf
-
Frohmader, T.J., Chaboyer, W.P., Robertson, I.K. and Gowardman, J., 2010. Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL# 3: a pilot trial. American Journal of Critical Care 19: e1-e11.
'Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL# 3: a pilot trial ' () 19 American Journal of Critical Care : e1 -e11.
-
Fujimori, S., Gudis, K., Mitsui, K., Seo, T., Yonezawa, M., Tanaka, S., Tatsuguchi, A. and Sakamoto, C., 2009. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 25: 520-525.
'A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis ' () 25 Nutrition : 520 -525.
-
Gao, X.W., Mubasher, M., Fang, C.Y., Reifer, C. and Miller, L.E., 2010. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. American Journal of Gastroenterology 105: 1636-1641.
'Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients ' () 105 American Journal of Gastroenterology : 1636 -1641.
-
Gianotti, L., Morelli, L., Galbiati, F., Rocchetti, S., Coppola, S., Beneduce, A., Gilardini, C., Zonenschain, D., Nespoli, A. and Braga, M., 2010. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World Journal of Gastroenterology 16: 167.
'A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients ' () 16 World Journal of Gastroenterology : 167.
-
González-Hernández, L.A., Jave-Suarez, L.F., Fafutis-Morris, M., Montes-Salcedo, K.E., Valle-Gutierrez, L.G., Campos-Loza, A.E., Enciso-Gómez, L.F. and Andrade-Villanueva, J.F., 2012. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial. Nutrition Journal 11: 90.
'Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial ' () 11 Nutrition Journal : 90.
-
Guarner, F., Khan, A.G., Garisch, J., Eliakim, R., Gangl, A., Thomson, A., Krabshuis, J., Lemair, T., Kaufmann, P., De Paula, J.A., Fedorak, R., Shanahan, F., Sanders, M.E., Szajewska, H., Ramakrishna, B.S., Karakan, T. and Kim, N., 2012. World gastroenterology organisation global guidelines: probiotics and prebiotics October 2011. Journal of Clinical Gastroenterology 46: 468-481.
'World gastroenterology organisation global guidelines: probiotics and prebiotics October 2011 ' () 46 Journal of Clinical Gastroenterology : 468 -481.
-
Hempel, S., Newberry, S.J., Maher, A.R., Wang, Z., Miles, J.N., Shanman, R., Johnsen, R. and Shekelle, P.G., 2012. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307: 1959-1969.
'Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis ' () 307 JAMA : 1959 -1969.
-
Hempel, S., Newberry, S., Ruelaz, A., Wang, Z., Miles, J.N.V., Suttorp, M.J., Johnsen, B., Shanman, R., Slusser, W., Fu, N., Smith, A., Roth, E., Polak, J., Motala, A., Perry, T. and Shekelle, P.G., 2011. Safety of probiotics to reduce risk and prevent or treat disease. Evidence Report/Technology Assessment No. 200. AHRQ Publication No. 11-E007. Agency for Healthcare Research and Quality, Rockville, MD, USA. Available at: http://www.ahrq.gov/clinic/tp/probiotictp.htm
-
Hemsworth, J.C., Hekmat, S. and Reid, G., 2012. Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Gut Microbes 3: 414-419.
'Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada ' () 3 Gut Microbes : 414 -419.
-
Horvat, M., Krebs, B., Potrč, S., Ivanecz, A. and Kompan, L., 2010. Preoperative synbiotic bowel conditioning for elective colorectal surgery. Wiener Klinische Wochenschrift, 122: 26-30.
'Preoperative synbiotic bowel conditioning for elective colorectal surgery ' () 122 Wiener Klinische Wochenschrift : 26 -30.
-
Hummelen, R., Changalucha, J., Butamanya, N.L., Cook, A., Habbema, J.D.F. and Reid, G., 2010. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. International Journal of Gynecology and Obstetrics, 111: 245-248.
'Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV ' () 111 International Journal of Gynecology and Obstetrics : 245 -248.
-
Hummelen, R., Changalucha, J., Butamanya, N.L., Koyama, T.E., Cook, A., Habbema, J.D. F. and Reid, G., 2011a. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes 2: 80-85.
'Effect of 25 weeks probiotic supplementation on immune function of HIV patients ' () 2 Gut Microbes : 80 -85.
-
Hummelen, R., Hemsworth, J., Changalucha, J., Butamanya, N.L., Hekmat, S., Habbema, J.D.F. and Reid, G., 2011b. Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients. Nutrients 3: 897-909.
'Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients ' () 3 Nutrients : 897 -909.
-
Irvine, S.L., Hummelen, R. and Hekmat, S., 2011. Probiotic yogurt consumption may improve gastrointestinal symptoms, productivity, and nutritional intake of people living with human immunodeficiency virus in Mwanza, Tanzania. Nutrition Research 31: 875-881.
'Probiotic yogurt consumption may improve gastrointestinal symptoms, productivity, and nutritional intake of people living with human immunodeficiency virus in Mwanza, Tanzania ' () 31 Nutrition Research : 875 -881.
-
Irvine, S.L., Hummelen, R., Hekmat, S., Looman, C.W., Habbema, J.D.F. and Reid, G., 2010. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. Journal of Clinical Gastroenterology 44: e201-e205.
'Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS ' () 44 Journal of Clinical Gastroenterology : e201 -e205.
-
Ishikawa, H., Matsumoto, S., Ohashi, Y., Imaoka, A., Setoyama, H., Umesaki, Y., Tanaka, R. and Otani, T., 2011. Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Digestion 84: 128-133.
'Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study ' () 84 Digestion : 128 -133.
-
Jenks, K., Stebbings, S., Burton, J., Schultz, M., Herbison, P. and Highton, J., 2010. Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. Journal of Rheumatology 37: 2118-2125.
'Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial ' () 37 Journal of Rheumatology : 2118 -2125.
-
Kamada, N., Chen, G.Y., Inohara, N. and Núñez, G., 2013. Control of pathogens and pathobionts by the gut microbiota. Nature Immunology 14: 685-690.
'Control of pathogens and pathobionts by the gut microbiota ' () 14 Nature Immunology : 685 -690.
-
Kirpich, I.A., Solovieva, N.V., Leikhter, S.N., Shidakova, N.A., Lebedeva, O.V., Sidorov, P.I., Bazhukova, T.A., Soloviev, A.G., Barve, S.S., McClain, C.J. and Cave, M., 2008. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 42: 675-682.
'Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study ' () 42 Alcohol : 675 -682.
-
Klarin, B., Molin, G., Jeppsson, B. and Larsson, A., 2008. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Critical Care 12: R136.
'Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study ' () 12 Critical Care : R136.
-
Knight, D.J., Gardiner, D., Banks, A., Snape, S.E., Weston, V.C., Bengmark, S. and Girling, K.J., 2009. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Medicine 35: 854-861.
'Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial ' () 35 Intensive Care Medicine : 854 -861.
-
Kollef, M.H., 2005. What is ventilator-associated pneumonia and why is it important? Respiratory Care 50: 714-724.
'What is ventilator-associated pneumonia and why is it important? ' () 50 Respiratory Care : 714 -724.
-
Lee, H.J., Waller, R.D., Stebbings, S., Highton, J., Orlovich, D.A., Schmierer, D. and Fawcett, J.P., 2010. The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study. International Journal of Rheumatic Diseases 13: 48-54.
'The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study ' () 13 International Journal of Rheumatic Diseases : 48 -54.
-
Leserman, J., Petitto, J.M., Gu, H., Gaynes, B.N., Barroso, J., Golden, R.N., Perkins, D.O., Folds, J.D. and Evans, D.L., 2002. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychological Medicine 32: 1059-1073.
'Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors ' () 32 Psychological Medicine : 1059 -1073.
-
Liu, J.E., Zhang, Y., Zhang, J., Dong, P.L., Chen, M. and Duan, Z.P., 2010. Probiotic yogurt effects on intestinal flora of patients with chronic liver disease. Nursing Research 59: 426-432.
'Probiotic yogurt effects on intestinal flora of patients with chronic liver disease ' () 59 Nursing Research : 426 -432.
-
Liu, Z.H., Huang, M.J., Zhang, X.W., Wang, L., Huang, N.Q., Peng, H., Lan, P., Peng, J.S., Yang, Z., Xia, Y., Liu, W.J., Yang, J., Qin, H.L. and Wang, J.P., 2013. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. American Journal of Clinical Nutrition 97: 117-126.
'The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial ' () 97 American Journal of Clinical Nutrition : 117 -126.
-
Liu, Z., Qin, H., Yang, Z., Xia, Y., Liu, W., Yang, J., Jiang, Y., Zhang, H., Yang, Z., Wang, Y. and Zheng, Q., 2011. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery – a double-blind study. Alimentary Pharmacology and Therapeutics 33: 50-63.
'Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery – a double-blind study ' () 33 Alimentary Pharmacology and Therapeutics : 50 -63.
-
Malaguarnera, M., Gargante, M.P., Malaguarnera, G., Salmeri, M., Mastrojeni, S., Rampello, L., Pennisi, G., Volti, G.L. and Galvano, F., 2010. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. European Journal of Gastroenterology and Hepatology 22: 199-206.
'Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy ' () 22 European Journal of Gastroenterology and Hepatology : 199 -206.
-
Mandel, D., Eichas, K. and Holmes, J., 2010. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complementary and Alternative Medicine 10: 1.
'Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial ' () 10 BMC Complementary and Alternative Medicine : 1.
-
Mangell, P., Thorlacius, H., Syk, I., Ahrné, S., Molin, G., Olsson, C. and Jeppsson, B., 2012. Lactobacillus plantarum 299v does not reduce enteric bacteria or bacterial translocation in patients undergoing colon resection. Digestive Diseases and Sciences 57: 1915-1924.
'Lactobacillus plantarum 299v does not reduce enteric bacteria or bacterial translocation in patients undergoing colon resection ' () 57 Digestive Diseases and Sciences : 1915 -1924.
-
Marchetti, G., Tincati, C. and Silvestri, G., 2013. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clinical Microbiology Reviews 26: 2-18.
'Microbial translocation in the pathogenesis of HIV infection and AIDS ' () 26 Clinical Microbiology Reviews : 2 -18.
-
Matthes, H., Krummenerl, T., Giensch, M., Wolff, C. and Schulze, J., 2010. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917. BMC Complementary and Alternative Medicine 10: 13.
'Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 ' () 10 BMC Complementary and Alternative Medicine : 13.
-
Mehandru, S., Poles, M.A., Tenner-Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D., Racz, P. and Markowitz, M., 2004. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. Journal of Experimental Medicine 200: 761-770.
'Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract ' () 200 Journal of Experimental Medicine : 761 -770.
-
Mennigen, R. and Bruewer, M., 2009. Effect of probiotics on intestinal barrier function. Annals of the New York Academy of Sciences 1165: 183-189.
'Effect of probiotics on intestinal barrier function ' () 1165 Annals of the New York Academy of Sciences : 183 -189.
-
Mittal, V.V., Sharma, B.C., Sharma, P. and Sarin, S.K., 2011. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. European Journal of Gastroenterology and Hepatology 23: 725-732.
'A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy ' () 23 European Journal of Gastroenterology and Hepatology : 725 -732.
-
Mookerjee, R.P., Stadlbauer, V., Lidder, S., Wright, G.A., Hodges, S.J., Davies, N.A. and Jalan, R., 2007. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology 46: 831-840.
'Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome ' () 46 Hepatology : 831 -840.
-
Morrow, L.E., Gogineni, V. and Malesker, M.A., 2012. Probiotic, prebiotic, and synbiotic use in critically ill patients. Current Opinion in Critical Care 18: 186-191.
'Probiotic, prebiotic, and synbiotic use in critically ill patients ' () 18 Current Opinion in Critical Care : 186 -191.
-
Morrow, L.E., Kollef, M.H. and Casale, T.B., 2010. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. American journal of Respiratory and Critical Care Medicine 182: 1058.
'Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial ' () 182 American journal of Respiratory and Critical Care Medicine : 1058.
-
Peguet-Navarro, J., Dezutter-Dambuyant, C., Buetler, T., Leclaire, J., Smola, H., Blum, S., Bastien, P., Breton, L. and Gueniche, A., 2008. Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial. European Journal of Dermatology 18: 504-511.
'Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial ' () 18 European Journal of Dermatology : 504 -511.
-
Peral, M.C., Huaman Martinez, M.A. and Valdez, J.C., 2009. Bacteriotherapy with Lactobacillus plantarum in burns. International Wound Journal 6: 73-81.
'Bacteriotherapy with Lactobacillus plantarum in burns ' () 6 International Wound Journal : 73 -81.
-
Pereg, D., Kotliroff, A., Gadoth, N., Hadary, R., Lishner, M. and Kitay-Cohen, Y., 2011. Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study. Nutrition 27: 177-181.
'Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study ' () 27 Nutrition : 177 -181.
-
Pineiro, M., Asp, N.G., Reid, G., Macfarlane, S., Morelli, L., Brunser, O. and Tuohy, K., 2008. FAO technical meeting on prebiotics. Journal of Clinical Gastroenterology 42: S156-S159.
'FAO technical meeting on prebiotics ' () 42 Journal of Clinical Gastroenterology : S156 -S159.
-
Pithadia, A.B. and Jain, S., 2011. Treatment of inflammatory bowel disease (IBD). Pharmacological Reports 63: 629-642.
'Treatment of inflammatory bowel disease (IBD) ' () 63 Pharmacological Reports : 629 -642.
-
Pozzoni, P., Riva, A., Bellatorre, A.G., Amigoni, M., Redaelli, E., Ronchetti, A., Stefani, M., Tironi, R., Molteni, E.E., Conte, D., Casazza, G. and Colli, A., 2012. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. American Journal of Gastroenterology 107: 922-931.
'Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial ' () 107 American Journal of Gastroenterology : 922 -931.
-
Ranganathan, N., Friedman, E.A., Tam, P., Rao, V., Ranganathan, P. and Dheer, R., 2009. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Current Medical Research and Opinion 25: 1919-1930.
'Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada ' () 25 Current Medical Research and Opinion : 1919 -1930.
-
Riordan, S.M. and Williams, R., 2006. The intestinal flora and bacterial infection in cirrhosis. Journal of Hepatology 45: 744-757.
'The intestinal flora and bacterial infection in cirrhosis ' () 45 Journal of Hepatology : 744 -757.
-
Saavedra, J.M., 2001. Clinical applications of probiotic agents. American Journal of Clinical Nutrition 73: 1147S-1151S.
'Clinical applications of probiotic agents. American Journal of Clinical Nutrition ' () 73 American Journal of Clinical Nutrition : 1147S -1151S.
-
Salminen, M.K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V. and Järvinen, A., 2004. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clinical Infectious Diseases 38: 62-69.
'Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG ' () 38 Clinical Infectious Diseases : 62 -69.
-
Salminen, M.K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V. and Järvinen, A., 2002. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clinical Infectious Diseases 35: 1155-1160.
'Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland ' () 35 Clinical Infectious Diseases : 1155 -1160.
-
Sanders, M.E., Guarner, F., Guerrant, R., Holt, P.R., Quigley, E.M., Sartor, R.B., Sherman, P.M. and Mayer, E.A., 2013. An update on the use and investigation of probiotics in health and disease. Gut 62: 787-796.
'An update on the use and investigation of probiotics in health and disease ' () 62 Gut : 787 -796.
-
Schroeder, R.A., Marroquin, C.E., Bute, B.P., Khuri, S., Henderson, W.G. and Kuo, P.C., 2006. Predictive indices of morbidity and mortality after liver resection. Annals of Surgery 243: 373.
'Predictive indices of morbidity and mortality after liver resection ' () 243 Annals of Surgery : 373.
-
Schuijt, T.J., Van der Poll, T., De Vos, W.M. and Wiersinga, W.J., 2013. The intestinal microbiota and host immune interactions in the critically ill. Trends in Microbiology 21: 221-229.
'The intestinal microbiota and host immune interactions in the critically ill ' () 21 Trends in Microbiology : 221 -229.
-
Schunter, M., Chu, H., Hayes, T.L., McConnell, D., Crawford, S.S., Luciw, P.A., Bengmark, S., Asmuth, D.M., Brown, J., Bevins, C.L., Shacklett, B.L. and Critchfield, J.W., 2012. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection. BMC Complementary and Alternative Medicine 12: 84.
'Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection Medicine ' () 12 BMC Complementary and Alternative : 84.
-
Sharma, B., Srivastava, S., Singh, N., Sachdev, V., Kapur, S. and Saraya, A., 2011. Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial. Journal of Clinical Gastroenterology 45: 442-448.
'Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial ' () 45 Journal of Clinical Gastroenterology : 442 -448.
-
Shimizu, K., Ogura, H., Goto, M., Asahara, T., Nomoto, K., Morotomi, M., Matsushima, A., Tasaki, O., Fujita, K., Hosotsubo, H., Kuwagata, H., Tanaka, H., Shimazu, T. and Sugimoto, H., 2009. Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report. Digestive Diseases and Sciences 54: 1071-1078.
'Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report ' () 54 Digestive Diseases and Sciences : 1071 -1078.
-
Song, H.J., Kim, J.Y., Jung, S., Kim, S.E., Park, H.S., Jeong, Y., Hong, S.P., Cheon, J.H., Kim, W.H., Kim, H.J., Ye, B.D., Yang, S.K., Kim, S.W., Shin, S.J., Kim. H.S., Sung, J.K. and Kim, E.Y., 2010. Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study. Journal of Korean Medical Science 25: 1784-1791.
'Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study ' () 25 Journal of Korean Medical Science : 1784 -1791.
-
Souza, D.N.P.D. and Jorge, M.T., 2012. The effect of Lactobacillus casei and Bifidobacterium breve on antibiotic-associated diarrhea treatment: randomized double-blind clinical trial. Revista da Sociedade Brasileira de Medicina Tropical 45: 112-116.
'The effect of Lactobacillus casei and Bifidobacterium breve on antibiotic-associated diarrhea treatment: randomized double-blind clinical trial ' () 45 Revista da Sociedade Brasileira de Medicina Tropical : 112 -116.
-
Stadlbauer, V., Mookerjee, R. P., Hodges, S., Wright, G.A., Davies, N.A. and Jalan, R., 2008. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. Journal of Hepatology 48: 945-951.
'Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis ' () 48 Journal of Hepatology : 945 -951.
-
Steed, H., Macfarlane, G.T., Blackett, K.L., Bahrami, B., Reynolds, N., Walsh, S.V., Cummings, J.H. and Macfarlane, S., 2010. Clinical trial: the microbiological and immunological effects of synbiotic consumption – a randomized double-blind placebo-controlled study in active Crohn's disease. Alimentary Pharmacology and Therapeutics 32: 872-883.
'Clinical trial: the microbiological and immunological effects of synbiotic consumption – a randomized double-blind placebo-controlled study in active Crohn's disease ' () 32 Alimentary Pharmacology and Therapeutics : 872 -883.
-
Stephens, J.H. and Hewett, P.J., 2012. Clinical trial assessing VSL# 3 for the treatment of anterior resection syndrome. ANZ Journal of Surgery 82: 420-427.
'Clinical trial assessing VSL# 3 for the treatment of anterior resection syndrome ' () 82 ANZ Journal of Surgery : 420 -427.
-
Tan, M., Zhu, J.C., Du, J., Zhang, L.M. and Yin, H.H., 2011. Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Critical Care 15: R290.
'Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study ' () 15 Critical Care : R290.
-
Tanaka, K., Yano, M., Motoori, M., Kishi, K., Miyashiro, I., Ohue, M., Ohigashi, H., Asahara, T., Nomoto, K. and Ishikawa, O., 2012. Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial. Surgery 152: 832-842.
'Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial ' () 152 Surgery : 832 -842.
-
Tandon, P., Moncrief, K., Madsen, K., Arrieta, M.C., Owen, R.J., Bain, V.G., Wong, W.W. and Ma, M.M., 2009. Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study. Liver International 29: 1110-1115.
'Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study ' () 29 Liver International : 1110 -1115.
-
Tran, K.T., Smeenk, H.G., Van Eijck, C.H., Kazemier, G., Hop, W.C., Greve, J.W.G., Terpstra, O.T., Zijlstra, J.A., Klinkert, P. and Jeekel, H., 2004. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Annals of Surgery 240: 738.
'Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors ' () 240 Annals of Surgery : 738.
-
Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G.M., Forti, G., Morini, S., Hassan, C., Pistoia, M.A., Modeo, M.E., Rodino, S., D'Amico, T., Sebkova, L., Sacca, N., Di Giulio, E., Luzza, F., Imeneo, M., Larussa, T., Di Rosa, S., Annese, V., Danese, S. and Gasbarrini, A., 2010. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. American Journal of Gastroenterology 105: 2218-2227.
'Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study ' () 105 American Journal of Gastroenterology : 2218 -2227.
-
Usami, M., Miyoshi, M., Kanbara, Y., Aoyama, M., Sakaki, H., Shuno, K., Hirata, K., Takahashi, M., Ueno, K., Tabata, S., Asahara, T. and Nomoto, K., 2011. Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. Journal of Parenteral and Enteral Nutrition 35: 317-328.
'Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis ' () 35 Journal of Parenteral and Enteral Nutrition : 317 -328.
-
Van den Nieuwboer, M., Claassen, E., Morelli, L., Guarner, F. and Brummer, R.J., 2014. Probiotic and synbiotic safety in infants under two years of age. Beneficial Microbes 5: 45-60.
'Probiotic and synbiotic safety in infants under two years of age ' () 5 Beneficial Microbes : 45 -60.
-
Vincent, J.L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C.D., Moreno, R., Lipman, J., Gomersall, C., Sakr, Y. and Reinhart, K., 2009. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302: 2323-2329.
'International study of the prevalence and outcomes of infection in intensive care units ' () 302 JAMA : 2323 -2329.
-
Von Wright, A., 2005. Regulating the safety of probiotics – the European approach. Current Pharmaceutical Design 11: 17-23.
'Regulating the safety of probiotics – the European approach ' () 11 Current Pharmaceutical Design : 17 -23.
-
Vyas, U. and Ranganathan, N., 2012. Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterology Research and Practice 2012: 16.
'Probiotics, prebiotics, and synbiotics: gut and beyond ' () 2012 Gastroenterology Research and Practice : 16.
-
Wagner, R.D. and Balish, E., 1998. Potential hazards of probiotic bacteria for immunodeficient patients. Bulletin de l’Institut Pasteur 96: 165-170.
'Potential hazards of probiotic bacteria for immunodeficient patients ' () 96 Bulletin de l’Institut Pasteur : 165 -170.
-
Wang, Q., Dong, J. and Zhu, Y., 2012. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. Journal of Pediatric Surgery 47: 241-248.
'Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials ' () 47 Journal of Pediatric Surgery : 241 -248.
-
Watkinson, P.J., Barber, V.S., Dark, P. and Young, J.D., 2007. The use of pre-pro-and synbiotics in adult intensive care unit patients: systematic review. Clinical Nutrition 26: 182-192.
'The use of pre-pro-and synbiotics in adult intensive care unit patients: systematic review ' () 26 Clinical Nutrition : 182 -192.
-
Zhang, J.W., Du, P., Gao, J., Yang, B.R., Fang, W.J. and Ying, C.M., 2012. Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. American Journal of the Medical Sciences 343: 199-205.
'Preoperative probiotics decrease postoperative infectious complications of colorectal cancer ' () 343 American Journal of the Medical Sciences : 199 -205.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 422 | 352 | 34 |
| PDF Views & Downloads | 449 | 372 | 27 |
The administration of probiotics and synbiotics in immune compromised adults: is it safe?
In: Beneficial MicrobesSearch for other papers by M. Van den Nieuwboer in
Current site
Google Scholar
PubMed
Search for other papers by R.J. Brummer in
Current site
Google Scholar
PubMed
Search for other papers by F. Guarner in
Current site
Google Scholar
PubMed
Search for other papers by L. Morelli in
Current site
Google Scholar
PubMed
Search for other papers by M. Cabana in
Current site
Google Scholar
PubMed
Search for other papers by E. Claassen in
Current site
Google Scholar
PubMed
This study aimed to systematically evaluate safety of probiotics and synbiotics in immune compromised adults (≥18 years). Safety was analysed using the Common Terminology Clinical Adverse Events (CTCAE version 4.0) classification, thereby providing an update on previous reports using the most recent available clinical data (2008-2013). Safety aspects are represented and related to number of participants per probiotic strain/culture, study duration, dosage, clinical condition and selected afflictions. Analysis of 57 clinical studies indicates that probiotic and/or synbiotic administration in immune compromised adults is safe with regard to the current evaluated probiotic strains, dosages and duration. Individuals were considered immune compromised if HIV-infected, critically ill, underwent surgery or had an organ- or an autoimmune disease. There were no major safety concerns in the study, as none of the serious adverse events (AE)s were related, or suspected to be related, to the probiotic or synbiotic product and the study products were well tolerated. Overall, AEs occurred less frequent in immune compromised subjects receiving probiotics and/or synbiotics compared to the control group. In addition, the results demonstrated a flaw in precise reporting and classification of AE in most studies. Furthermore, generalisability of conclusions are greatly limited by the inconsistent, imprecise and potentially incomplete reporting as well as the variation in probiotic strains, dosages, administration regimes, study populations and reported outcomes. We argue that standardised reporting on adverse events (CTCAE) in ‘food’ studies should be obligatory, thereby improving reliability of data and re-enforcing the safety profile of probiotics.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 422 | 352 | 34 |
| PDF Views & Downloads | 449 | 372 | 27 |
